Envestnet Asset Management
MAIA icon

Envestnet Asset Management’s MAIA Biotechnology MAIA Stock Holding History

Envestnet Asset Management’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$63.9K Buy
+44,347
New +$58.9K ﹤0.01% 4784

Other funds holding MAIA

CWM
Centric Wealth Management Chicago, Illinois $643M AUM 21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BFG
Bleakley Financial Group Fairfield, New Jersey $7.85B AUM 31.48% 1-Year Est. Return
PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
LCM
Lazari Capital Management Woodland Hills, California $325M AUM 32.83% 1-Year Est. Return
AI
Atria Investments Charlotte, North Carolina $9.98B AUM 26.5% 1-Year Est. Return
CAG
Centerpoint Advisory Group Overland Park, Kansas $158M AUM 26.37% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
DSC
Daytona Street Capital Saint Louis, Missouri $137M AUM

Envestnet Asset Management's MAIA Position: Q2 2026 in Review

Envestnet Asset Management opened a new position in MAIA Biotechnology (MAIA) in Q2 2026: 44,347 shares worth $63.9K. The stake represents ﹤0.01% of the portfolio and ranks #4784 among its holdings.

13 funds tracked by Wall St. Rank hold MAIA as of Q2 2026.

  • Envestnet Asset Management held 44,347 shares of MAIA Biotechnology worth $63.9K as of Q2 2026.
  • MAIA Biotechnology was a new Envestnet Asset Management position in Q2 2026.
  • MAIA Biotechnology made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #4784 holding.
  • 13 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.